LOGIN  |  REGISTER
Viking Therapeutics
Cue Biopharma

Apollo Medical to Participate in Upcoming Investor Conferences

September 05, 2023 | Last Trade: US$24.90 0.71 -2.77

ALHAMBRA, Calif., Sept. 1, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that leadership is participating in the following investor conferences.

Morgan Stanley 21st Annual Global Healthcare Conference
Date: Wednesday, September 13, 2023, including a fireside chat presentation at 11:15 a.m. PT/2:15 p.m. ET
Venue: Sheraton New York

Lake Street Capital Markets 2023 BIG7 Conference 
Date: Thursday, September 14, 2023
Venue: The Yale Club, New York

TD Cowen 8th Annual FutureHealth Conference 

This virtual conference incorporates fireside chats and innovative panel discussions hosted by members of the TD Cowen research team that focus on various aspects of the futurehealth industry. ApolloMed is participating in the Redesign of Physician Delivery Models: Primary Care Panel.
Date: Thursday, September 21, 2023, at 11:20 a.m. PT/2:20 p.m. ET

Management will be participating in one-on-one and small group meetings at the Morgan Stanley and Lake Street Capital Markets events in New York. Those interested in attending any of these conferences should reach out to their respective representatives. The Company's presentations at the Morgan Stanley conference will be made available via live webcast and in archive following the conclusion of each event at the "Events" page of the Company's website: https://www.apollomed.net/news-media/events.

About Apollo Medical Holdings, Inc.

ApolloMed is a leading physician-centric, technology-powered, risk-bearing healthcare management company. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.

Headquartered in Alhambra, California, ApolloMed's subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), and entities participating in the Centers for Medicare & Medicaid Services Innovation Center (CMMI) innovation models. For more information, please visit www.apollomed.net.

FOR MORE INFORMATION, PLEASE CONTACT:

Investor Relations
(626) 943-6491
This email address is being protected from spambots. You need JavaScript enabled to view it.

Carolyne Sohn, The Equity Group
(408) 538-4577
This email address is being protected from spambots. You need JavaScript enabled to view it.

Chimerix

Stock Quote

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page